June 1, 2019EuroIntervention110 citations
View Full PaperOptimising patient discharge management after transfemoral transcatheter aortic valve implantation: the multicentre European FAST-TAVI trial
Structured PICO
Does a pre-specified set of risk criteria for timely discharge increase 30-day complications in patients after transfemoral TAVI?
P
Population
Patients undergoing transfemoral transcatheter aortic valve implantation (TAVI)
I
Intervention
Discharge management using a pre-specified set of risk criteria for safe and timely discharge
C
Comparator
Reported outcomes in major TAVI trials and registries
O
Outcome
30-day complicationssafety
Using pre-specified risk criteria for timely discharge after transfemoral TAVI is safe and does not increase 30-day complications.
Abstract
We validated the appropriateness of a pre-specified set of risk criteria that allows a safe and timely discharge. The rate of 30-day complications did not reveal any risk increase with this strategy compared with the reported outcomes in major TAVI trials and registries. ClinicalTrials.gov Identifier: NCT02404467.